Finance

Beta
Lists
HRTIS:HEL
Herantis Pharma Oyj
€1.88
-5.43%
(-0.11) 1D
Jun 4, 6:29:32 PM GMT+3  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HRTIS...
Open
€1.99
High
€1.99
Low
€1.88
Mkt. cap
49.88M
Avg. vol.
34.18K
Volume
16.82K
52-wk high
€3.87
52-wk low
€1.22
EPS
-€0.28
Shares outstanding
26.50M
No. of employees
13
Open
€1.99
High
€1.99
Low
€1.88
Mkt. cap
49.88M
Avg. vol.
34.18K
Volume
16.82K
52-wk high
€3.87
52-wk low
€1.22
EPS
-€0.28
Shares outstanding
26.50M
No. of employees
13
News stories
From sources across the web
About Herantis Pharma Oyj
CEOAntti Vuolanto
Employees13
Founded2008
Headquarters-
SectorPharmaceutical industry
Websiteherantis.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
557.50K
557.50K
402.99K
402.99K
Operating expense
1.48M
1.48M
1.72M
1.72M
Total operating expenses
1.48M
1.48M
1.72M
1.72M
Operating income
-1.48M
-1.48M
-1.72M
-1.72M
Other non operating income
31.50K
31.50K
-150.07K
-150.07K
EBT including unusual items
-1.60M
-1.60M
-1.71M
-1.71M
EBT excluding unusual items
-1.60M
-1.60M
-1.71M
-1.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
920.00K
920.00K
1.32M
1.32M
Net income
-1.60M
-1.60M
-1.71M
-1.71M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
9.00K
9.00K
160.84K
160.84K
Interest expense
-163.50K
-163.50K
-
-
Net interest expenses
-154.50K
-154.50K
160.84K
160.84K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer